Non-infectious mechanisms of neurological damage due to infection


Posted: 2021-11-20 20:00:00
Review J Neurol Sci . 2021 Nov 11;431:120057. doi: 10.1016/j.jns.2021.120057. Online ahead of print. Affiliations Expand Affiliations 1 Felsenstein Medical Research Center, Petach Tikva, Israel; Department of Neurology, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: benninger@tauex.tau.ac.il. 2 Department of Neurology, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: israels2@clalit.org.il. Item in Clipboard Review Felix Benninger et al. J Neurol Sci. 2021. Show details Display options Display options Format J Neurol Sci . 2021 Nov 11;431:120057. doi: 10.1016/j.jns.2021.120057. Online ahead of print. Affiliations 1 Felsenstein Medical Research Center, Petach Tikva, Israel; Department of Neurology, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: benninger@tauex.tau.ac.il. 2 Department of Neurology, Rabin Medical Center, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: israels2@clalit.org.il. Item in Clipboard CiteDisplay options Display options Format Abstract Infections of the nervous system is a growing aspect of clinical neurology. Accumulating knowledge in early diagnosis, course, therapy and prognosis is enlarging the clinical tools required for effective therapy. Of special importance is the ability to differentiate between proper infections, where anti-microbial agents, when available, should be introduced and used and post infectious conditions where therapy is mainly directed against the host immune system. The two conditions sometimes overlap, a situation that requires the ability to combine clinical skills with the use of laboratory tools such as polymerase chain reaction (PCR), serology, and antigenic detection. In the era of the SARS-CoV-2 pandemic, the need to make this distinction is emphasized as correct diagnosis of post infectious conditions and expedited therapy is important and sometimes lifesaving. We here attempt to present several infectious agents and their possible indirect damage to the nervous system causing in some cases significant neurological deficits. We try to limit our focus on those mechanisms which do not involve the direct tissue damage by the infectious agents but rather are connected to para- and post-infectious mechanisms. We attempt to delineate the features that will enable to tailor the correct diagnosis and following the effective therapy. Keywords: Infection; Inflammation; Neurology; Post-infectious. Copyright © 2021. Published by Elsevier B.V. Publication types [x] Cite Copy Format: Send To [x]

参考サイト PubMed: covid-19



バイオクイックニュース日本語版:COVID-19特集

バイオクイックニュース日本語版
3月 31, 2021 バイオアソシエイツ

宿主遺伝子の発現を阻害するウイルスタンパク質(Nsp1)を標的としたCOVID-19治療アプローチの可能性

Nsp1と呼ばれるコロナウイルスタンパク質が遺伝子の活性をどのように抑制し、ウイルス複製を促進するかを特定する研究は、新しい COVID-19 治療への希望をもたらすものだ。 パンデミックが始まって以来、科学者らは、 COVID-19 の原因となるコロナウイルスであるSARS-CoV-2を理解するために果てしなく取り組んできた。ワクチンの登場にもかかわらず、ウイルスはまだ蔓延しており、代替療法を開発する必要がある。…

ゲスト 888人 と メンバー 5人 がオンラインです